Routine antenatal tests.
Numerous tests have been proposed in recent years to screen the antenatal population for various diseases which might contribute to perinatal and even maternal morbidity and mortality. Screening tests of any kind are currently the centre of controversy as measures are being strenuously taken to contain health costs. This paper critically examines twelve such screening tests.
D000293:Adolescent; D000328:Adult; D001437:Bacteriuria / Q000175:diagnosis; D001789:Blood Group Antigens; D002582:Cervix Mucus / Q000166:cytology; D004964:Estriol / Q000652:urine; D005260:Female; D005951:Glucose Tolerance Test; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D010661:Phenylketonurias / Q000175:diagnosis; D011247:Pregnancy; D011248:Pregnancy Complications / Q000175:diagnosis*; D011250:Pregnancy Complications, Hematologic / Q000175:diagnosis; D011295:Prenatal Care / Q000592:standards*; D012409:Rubella / Q000276:immunology; D013587:Syphilis / Q000175:diagnosis; D000509:alpha-Fetoproteins / Q000032:analysis
D001789:Blood Group Antigens; D000509:alpha-Fetoproteins; D004964:Estriol